IBM Watson recently joined forces with MAP Health Management to fight substance abuse in the U.S. The partnership will focus on relapse reduction.
The Scope of America’s Addiction Crisis
Over 22.5 million Americans are caught in the snare of addiction, and of those, only 2.6 million are receiving treatment. This staggering treatment gap represents one of the most significant public health challenges facing our nation. The National Institute on Drug Abuse reported that the economic cost of substance abuse–related to crime, lost work productivity and health care–is near $700 billion. In 2015, opioid abuse claimed more American lives than car crashes and gun homicides combined.
These statistics underscore an urgent need for innovative approaches to addiction treatment and relapse prevention. Traditional methods, while valuable, often struggle to predict which patients are at highest risk for relapse or to identify the optimal timing and type of interventions for individual patients.
How Artificial Intelligence Can Transform Treatment
Jacob Levenson, CEO of MAP, described addiction as the “great crisis of our time.” He reported that the current method of “assessing, treating and paying for … care isn’t sustainable.” He believes that using “advanced cognitive technology” like Watson will improve treatment decisions, leading to improved long-term management for those suffering.
Watson’s artificial intelligence capabilities can process vast amounts of patient data—including treatment history, behavioral patterns, social determinants of health, and biological markers—to identify risk factors that human clinicians might miss. This predictive modeling allows treatment providers to intervene proactively rather than reactively.
Real-World Applications in Behavioral Health
Aetna Behavioral Health is planning to use MAP’s system to predict substance abuse relapses. The goal is to gather and analyze patient data in order to create long-term strategies to help patients reach and stay in recovery through relapse reduction.
By identifying patients at elevated risk before a relapse occurs, care teams can adjust treatment plans, increase support services, or modify medication-assisted treatment protocols. This personalized, data-driven approach represents a significant evolution in addiction medicine, moving from a one-size-fits-all model to precision behavioral health care.
Read on to learn more about technology in addiction recovery.